NIA
NIA Impact Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,620
| Closed | -$254K | – | 54 |
|
|
2023
Q1 | $254K | Sell |
5,620
-2,598
| -32% | -$118K | 0.14% | 48 |
|
|
2022
Q4 | $334K | Sell |
8,218
-4,660
| -36% | -$189K | 0.19% | 49 |
|
|
2022
Q3 | $842K | Sell |
12,878
-32,158
| -71% | -$2.1M | 0.52% | 49 |
|
|
2022
Q2 | $2.74M | Sell |
45,036
-35,046
| -44% | -$2.13M | 1.64% | 22 |
|
|
2022
Q1 | $5.03M | Buy |
80,082
+17,473
| +28% | +$1.1M | 2.44% | 16 |
|
|
2021
Q4 | $3.88M | Buy |
62,609
+2,110
| +3% | +$131K | 2.06% | 18 |
|
|
2021
Q3 | $6.77M | Buy |
60,499
+20,608
| +52% | +$2.31M | 2.89% | 14 |
|
|
2021
Q2 | $6.46M | Buy |
39,891
+1,999
| +5% | +$324K | 3.15% | 12 |
|
|
2021
Q1 | $4.62M | Buy |
37,892
+4,412
| +13% | +$538K | 2.5% | 19 |
|
|
2020
Q4 | $6.51M | Buy |
+33,480
| New | +$6.51M | 3.39% | 7 |
|